Change
Volume
52 Week High
52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Biogen
Corporate Profile
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
Biogen
Annual reports
